ConductScience.org, home

Paper39337361

The Role of Mutated Calreticulin in the Pathogenesis of BCR-ABL1-Negative Myeloproliferative Neoplasms.

Vadeikienė R and 5 others. Int J Mol Sci, 2024. Cited by 3 papers, by iCite.

Cite this record

ConductScience Library. The Role of Mutated Calreticulin in the Pathogenesis of BCR-ABL1-Negative Myeloproliferative Neoplasms. Papers, record 39337361. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39337361

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The Role of Mutated Calreticulin in the Pathogenesis of BCR-ABL1-Negative Myeloproliferative Neoplasms.
PubMed
Journal
Int J Mol Sci
PubMed
Year
2024
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
3
iCite
Relative citation ratio, by iCite
0.48, provisional
iCite
Revised in PubMed
2024-10-03
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Vadeikienė RRoberta
2Jakštys BBaltramiejushttps://orcid.org/0000-0002-6106-330X
3Laukaitienė DDanguolė
4Šatkauskas SSauliushttps://orcid.org/0000-0002-9001-7767
5Juozaitytė EElonahttps://orcid.org/0000-0001-6695-7786
6Ugenskienė RRasa

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
CalreticulinMajor topic
Fusion Proteins, bcr-ablMajor topic
MutationMajor topic
Myeloproliferative DisordersMajor topic
Humans
DNA Damage
Oxidative Stress
Phosphatidylinositol 3-Kinases
Signal Transduction
TOR Serine-Threonine Kinases

Source PubMed

Download CSV of topics

References93

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
117632527Essential role of stromally induced hedgehog signaling in B-cell malignancies.Nat Med2007https://conductscience.org/library/papers/17632527PubMed
224421250CALR mutation studies in chronic neutrophilic leukemia.Am J Hematol2014https://conductscience.org/library/papers/24421250PubMed
334193229Molecular pathogenesis of the myeloproliferative neoplasms.J Hematol Oncol2021https://conductscience.org/library/papers/34193229PubMed
429274272The role of the Hedgehog signaling pathway in cancer: A comprehensive review.Bosn J Basic Med Sci2018https://conductscience.org/library/papers/29274272PubMed
530754640mTOR Signaling in Cancer and mTOR Inhibitors in Solid Tumor Targeting Therapy.Int J Mol Sci2019https://conductscience.org/library/papers/30754640PubMed
68329702Establishment and characterization of an erythropoietin-dependent subline, UT-7/Epo, derived from human leukemia cell line, UT-7.Blood1993https://conductscience.org/library/papers/8329702PubMed
733312103CALR mutations in myeloproliferative neoplasms: An unfolding story.EXCLI J2020https://conductscience.org/library/papers/33312103PubMed
815781101Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders.Lancet2005https://conductscience.org/library/papers/15781101PubMed
924366362JAK2 or CALR mutation status defines subtypes of essential thrombocythemia with substantially different clinical course and outcomes.Blood2014https://conductscience.org/library/papers/24366362PubMed
1024895336Distinct clinical characteristics of myeloproliferative neoplasms with calreticulin mutations.Haematologica2014https://conductscience.org/library/papers/24895336PubMed
1125691811Hedgehog signaling in cancer stem cells: a focus on hematological cancers.Stem Cells Cloning2015https://conductscience.org/library/papers/25691811PubMed
1236611979Transcriptomic Analysis Reveals JAK2/MPL-Independent Effects of Calreticulin Mutations in a C. elegans Model.Cells2023https://conductscience.org/library/papers/36611979PubMed
1325641433Phase II evaluation of IPI-926, an oral Hedgehog inhibitor, in patients with myelofibrosis.Leuk Lymphoma2015https://conductscience.org/library/papers/25641433PubMed
1415793561A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera.Nature2005https://conductscience.org/library/papers/15793561PubMed
1515482598Activation of the hedgehog pathway in advanced prostate cancer.Mol Cancer2004https://conductscience.org/library/papers/15482598PubMed
1634645293Environmental Factors, Lifestyle Risk Factors, and Host Characteristics Associated With Philadelphia Negative Myeloproliferative Neoplasm: A Systematic Review.Cancer Control2021https://conductscience.org/library/papers/34645293PubMed
1729426921The 2016 WHO classification and diagnostic criteria for myeloproliferative neoplasms: document summary and in-depth discussion.Blood Cancer J2018https://conductscience.org/library/papers/29426921PubMed
1825918716Functional roles of calreticulin in cancer biology.Biomed Res Int2015https://conductscience.org/library/papers/25918716PubMed
1926538833The Role of Reactive Oxygen Species in Myelofibrosis and Related Neoplasms.Mediators Inflamm2015https://conductscience.org/library/papers/26538833PubMed
2021300928Circulating interleukin (IL)-8, IL-2R, IL-12, and IL-15 levels are independently prognostic in primary myelofibrosis: a comprehensive cytokine profiling study.J Clin Oncol2011https://conductscience.org/library/papers/21300928PubMed

See all 93 referencesDownload CSV of references

Cited by3

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.

PMIDTitleJournalYearIn PapersSource
42131291CDK6 inactivation counteracts CALR-mutant-induced MPN evolution and sensitizes MPN stem cells to interferon-α treatment.Hemasphere2026https://conductscience.org/library/papers/42131291PubMed
40105884Adefovir anticancer potential: Network pharmacology, anti-proliferative and apoptotic effects in HeLa cells.Biomol Biomed2025https://conductscience.org/library/papers/40105884PubMed
39519157Myeloproliferative Neoplasm-like Mutations of Calreticulin Induce Phenotypes Associated with Calreticulin Dysfunction in C. elegans.Int J Mol Sci2024https://conductscience.org/library/papers/39519157PubMed

Download CSV of cited by

Genes4

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
AKT1207PubTator's text mininghttps://conductscience.org/library/genes/207NCBI Gene
CALR811PubTator's text mininghttps://conductscience.org/library/genes/811NCBI Gene
MPL4352PubTator's text mininghttps://conductscience.org/library/genes/4352NCBI Gene
MTOR2475PubTator's text mininghttps://conductscience.org/library/genes/2475NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39337361

GET https://conductscience.org/api/papers/v1/39337361/references?page=2